Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Implications of IMW 2019 on nursing practices

Tanya Burton • 14 Sep 2019
IMW 2019
Amyloidosis Multiple Myeloma Rare Diseases Dexamethasone

Tanya Burton University Hospital of Wales, Cardiff, UK, shares her highlights and reflections from the nursing symposium attached to the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Tanya Burton

1:03
Multiple myeloma: what needs to change to improve care?
Tanya Burton • 2 Apr 2019
2:18
Self-administration of bortezomib in multiple myeloma: results from Cardiff
Tanya Burton • 2 Apr 2019
0:40
Approval of Dvd for myeloma at first relapse in the UK: impacts on care
Tanya Burton • 2 Apr 2019

Related Videos

0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
4:59
MRD as an endpoint for accelerating drug approval in multiple myeloma: updates from the ODAC meeting
Ola Landgren • 13 Apr 2024
The content of VJHemOnc is intended for healthcare professionals